Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studiesAdam Trickey, Jonathan A C Sterne, Caroline Sabin et al.|The Lancet HIV|2023Cited by 506
Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's diseaseChristian Hoffmann, Hans‐Reinhard Brodt, Kai Uwe Chow et al.|British Journal of Haematology|2004Cited by 92
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortiumLoveleen Bansi‐Matharu, Lene Ryom, Andrew Phillips et al.|The Lancet HIV|2021Cited by 65
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort studyPhilipp Schommers, Christian Hoffmann, Daniel Gillor et al.|Haematologica|2018Cited by 42
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom et al.|Clinical Infectious Diseases|2023Cited by 23